• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人工智能是否重新定义了诊断高级别尿路上皮癌的核质比阈值?

Does artificial intelligence redefine nuclear-to-cytoplasmic ratio threshold for diagnosing high-grade urothelial carcinoma?

作者信息

Yang Wei-Lei, Crothers Barbara A, Liu Tien-Jen, Hsu Shih-Wen, Yeh Cheng-Hung, Liu Yi-Siou, Shao Guowei, Lin Ming-Yu, Tsao Tang-Yi, Tung Min-Che, Chu Pei-Yi, Hang Jen-Fan

机构信息

AIxMed, Inc, Santa Clara, California, USA.

Department of Pathology, Tung's Taichung MetroHarbor Hospital, Taichung, Taiwan.

出版信息

Cancer Cytopathol. 2025 May;133(5):e70017. doi: 10.1002/cncy.70017.

DOI:10.1002/cncy.70017
PMID:40317981
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12049170/
Abstract

BACKGROUND

The Paris System (TPS) introduced standardized nuclear-to-cytoplasmic (N/C) ratio thresholds for urine cytology to improve high-grade urothelial carcinoma (HGUC) detection, but these criteria remain subjective. This study used AIxURO, an artificial intelligence-based model, to measure N/C ratio and nuclear area to identify abnormal cells in whole slide images (WSIs).

METHODS

A total of 106 urine cytology slides from 46 lower urinary tract (LUT) and 60 upper urinary tract (UUT) cancer cases, diagnosed as atypical urothelial cell (15.1%), suspicious for high-grade urothelial carcinoma (SHGUC) (23.6%), and HGUC (61.3%), with biopsy-confirmed HGUC or carcinoma in situ (CIS), were digitized and analyzed by AIxURO. The model quantified suspicious and atypical cells, N/C ratios, and nuclear areas, with statistical differences assessed using Kruskal-Wallis tests.

RESULTS

AIxURO identified fewer suspicious cells than atypical cells (20.5 vs. 242.0, p < .001). Suspicious cells had higher N/C ratios (0.66 vs. 0.58, p < .001) and larger nuclear areas (102.3 vs. 85.7 µm, p < .001). Although N/C ratios did not differ significantly between UUT and LUT cases, nuclear areas varied among abnormal cells (CIS: 101.5 µm; HGUC: 83.5 µm). In HGUC cytology cases, the CIS category had larger nuclear areas than HGUC for both suspicious (116.3 vs. 100.4 µm) and atypical cells (101.5 vs. 82.2 µm).

CONCLUSIONS

AIxURO provides objective quantification of N/C ratios and nuclear areas, refining TPS criteria for distinguishing suspicious from atypical cells. A lower N/C ratio cutoff (0.66) for SHGUC/HGUC may be more appropriate than the TPS threshold (>0.7). Findings support using consistent N/C ratio criteria across UUT and LUT cases.

摘要

背景

巴黎系统(TPS)引入了尿液细胞学标准化核质比(N/C)阈值,以提高高级别尿路上皮癌(HGUC)的检测率,但这些标准仍然主观。本研究使用基于人工智能的模型AIxURO测量N/C比和核面积,以识别全视野图像(WSIs)中的异常细胞。

方法

总共106张尿液细胞学玻片来自46例下尿路(LUT)和60例上尿路(UUT)癌症病例,诊断为非典型尿路上皮细胞(15.1%)、可疑高级别尿路上皮癌(SHGUC)(23.6%)和HGUC(61.3%),经活检证实为HGUC或原位癌(CIS),由AIxURO进行数字化分析。该模型对可疑和非典型细胞、N/C比和核面积进行量化,使用Kruskal-Wallis检验评估统计学差异。

结果

AIxURO识别出的可疑细胞比非典型细胞少(20.5对242.0,p <.001)。可疑细胞的N/C比更高(0.66对0.58,p <.001),核面积更大(102.3对85.7 µm,p <.001)。虽然UUT和LUT病例之间的N/C比没有显著差异,但异常细胞的核面积有所不同(CIS:101.5 µm;HGUC:83.5 µm)。在HGUC细胞学病例中,CIS类别中可疑细胞(116.3对100.4 µm)和非典型细胞(101.5对82.2 µm)的核面积均大于HGUC。

结论

AIxURO提供了N/C比和核面积的客观量化,完善了区分可疑细胞与非典型细胞的TPS标准。SHGUC/HGUC的较低N/C比临界值(0.66)可能比TPS阈值(>0.7)更合适。研究结果支持在UUT和LUT病例中使用一致的N/C比标准。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe0e/12049170/bea2bae20d90/CNCY-133-0-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe0e/12049170/b997ddcba390/CNCY-133-0-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe0e/12049170/fcc52ccdf73c/CNCY-133-0-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe0e/12049170/bea2bae20d90/CNCY-133-0-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe0e/12049170/b997ddcba390/CNCY-133-0-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe0e/12049170/fcc52ccdf73c/CNCY-133-0-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe0e/12049170/bea2bae20d90/CNCY-133-0-g001.jpg

相似文献

1
Does artificial intelligence redefine nuclear-to-cytoplasmic ratio threshold for diagnosing high-grade urothelial carcinoma?人工智能是否重新定义了诊断高级别尿路上皮癌的核质比阈值?
Cancer Cytopathol. 2025 May;133(5):e70017. doi: 10.1002/cncy.70017.
2
Digital image analysis supports a nuclear-to-cytoplasmic ratio cutoff value below 0.7 for positive for high-grade urothelial carcinoma and suspicious for high-grade urothelial carcinoma in urine cytology specimens.数字图像分析支持核质比截断值低于 0.7 用于尿液细胞学标本中高级尿路上皮癌的阳性和高级尿路上皮癌的可疑诊断。
Cancer Cytopathol. 2019 Feb;127(2):120-124. doi: 10.1002/cncy.22061. Epub 2018 Nov 5.
3
Split-sample comparison of urothelial cells in ThinPrep and cytospin preparations in urinary cytology: Do we need to adjust The Paris System for Reporting Urinary Cytology criteria?尿细胞学中 ThinPrep 和离心涂片中尿路上皮细胞的分样比较:我们是否需要调整《巴黎系统报告尿细胞学标准》?
Cancer Cytopathol. 2020 Feb;128(2):119-125. doi: 10.1002/cncy.22218. Epub 2019 Nov 27.
4
An Artificial Intelligence-assisted Diagnostic System Improves Upper Urine Tract Cytology Diagnosis.人工智能辅助诊断系统提高上尿路细胞学诊断水平。
In Vivo. 2024 Nov-Dec;38(6):3016-3021. doi: 10.21873/invivo.13785.
5
Digital image analysis supports a nuclear-to-cytoplasmic ratio cutoff value of 0.5 for atypical urothelial cells.数字图像分析支持非典型尿路上皮细胞的核质比临界值为0.5。
Cancer Cytopathol. 2017 Sep;125(9):710-716. doi: 10.1002/cncy.21883. Epub 2017 Jun 5.
6
Cytologic evaluation of upper urinary tract specimens: An institutional retrospective study using The Paris System for Reporting Urine Cytology second edition with histopathologic follow-up.上尿路标本的细胞学评估:采用第二代巴黎尿细胞学报告系统(附组织病理学随访)的机构回顾性研究。
Cytopathology. 2024 Mar;35(2):235-241. doi: 10.1111/cyt.13328. Epub 2023 Nov 2.
7
Quantitative cytomorphological comparison of SurePath and ThinPrep liquid-based cytology using high-grade urothelial carcinoma cells.应用液基细胞学技术的巴氏染色与液基薄层细胞学技术检测高级别尿路上皮癌的对比研究
Cytopathology. 2021 Sep;32(5):654-659. doi: 10.1111/cyt.12998. Epub 2021 Jun 10.
8
Diagnostic Accuracy of the Second Edition of the Paris System for Reporting High-Grade Urothelial Carcinoma in Urinary Cytology.《巴黎系统第二版用于报告尿细胞学高级别尿路上皮癌的诊断准确性》
Acta Cytol. 2024;68(6):525-531. doi: 10.1159/000541504. Epub 2024 Sep 18.
9
Implementation of The Paris System for Reporting Urine Cytology improves diagnostic accuracy of selective upper urinary tract cytology.《巴黎尿细胞学报告系统》的实施提高了选择性上尿路细胞学诊断的准确性。
Cancer Cytopathol. 2024 Apr;132(4):242-249. doi: 10.1002/cncy.22792. Epub 2024 Jan 31.
10
The Paris System for urine cytology in upper tract urothelial specimens: A comparative analysis with biopsy and surgical resection.上尿路尿路上皮标本的巴黎尿液细胞学系统:与活检和手术切除的比较分析
Cytopathology. 2018 Apr;29(2):184-188. doi: 10.1111/cyt.12505. Epub 2017 Dec 18.

本文引用的文献

1
A review of the performance of urinary cytology with a focus on atypia, upper tract and updates on novel ancillary testing.尿细胞学检查性能综述,重点关注异型性、上尿路以及新型辅助检测的进展。
J Am Soc Cytopathol. 2025 Jan-Feb;14(1):23-35. doi: 10.1016/j.jasc.2024.09.001. Epub 2024 Sep 19.
2
Utility of Image Morphometry in the Atypical Urothelial Cells and High-Grade Urothelial Carcinoma Categories of the Paris System for Reporting Urinary Cytology.图像形态测量法在巴黎系统报告尿细胞学的非典型尿路上皮细胞和高级别尿路上皮癌分类中的应用
J Cytol. 2024 Jul-Sep;41(3):137-142. doi: 10.4103/joc.joc_177_23. Epub 2024 Jul 18.
3
Evaluating artificial intelligence-enhanced digital urine cytology for bladder cancer diagnosis.
评估人工智能增强的数字尿液细胞学在膀胱癌诊断中的应用。
Cancer Cytopathol. 2024 Nov;132(11):686-695. doi: 10.1002/cncy.22884. Epub 2024 Jul 14.
4
Trends in the incidence of urothelial carcinoma in Taiwan after the ban on aristolochic acid-containing Chinese herbal preparations, 2001-2018: a national population-based cohort study.2001-2018 年台湾禁用含马兜铃酸中草药制剂后尿路上皮癌发病率的趋势:一项基于全国人群的队列研究。
J Cancer Res Clin Oncol. 2023 Sep;149(11):8201-8211. doi: 10.1007/s00432-023-04771-6. Epub 2023 Apr 15.
5
The usefulness of nuclear area in the diagnosis of high-grade urothelial carcinoma cells in voided urine cytology.核面积在尿脱落细胞学诊断高级别尿路上皮癌细胞中的作用。
Cytopathology. 2023 Jul;34(4):295-301. doi: 10.1111/cyt.13229. Epub 2023 Mar 23.
6
Evaluation of an artificial intelligence algorithm for assisting the Paris System in reporting urinary cytology: A pilot study.评估一种人工智能算法在协助巴黎系统报告尿细胞学中的应用:一项初步研究。
Cancer Cytopathol. 2022 Nov;130(11):872-880. doi: 10.1002/cncy.22615. Epub 2022 Jun 21.
7
An image-based flow cytometric approach to the assessment of the nucleus-to-cytoplasm ratio.基于图像的流式细胞术评估核质比。
PLoS One. 2021 Jun 24;16(6):e0253439. doi: 10.1371/journal.pone.0253439. eCollection 2021.
8
Quantitative cytomorphological comparison of SurePath and ThinPrep liquid-based cytology using high-grade urothelial carcinoma cells.应用液基细胞学技术的巴氏染色与液基薄层细胞学技术检测高级别尿路上皮癌的对比研究
Cytopathology. 2021 Sep;32(5):654-659. doi: 10.1111/cyt.12998. Epub 2021 Jun 10.
9
The Paris System for Reporting Urinary Cytology reduces atypia rates and does not alter the negative predictive value of urine cytology.巴黎尿细胞学报告系统降低了不典型率,并未改变尿细胞学的阴性预测值。
J Am Soc Cytopathol. 2021 Jan-Feb;10(1):14-19. doi: 10.1016/j.jasc.2020.09.002. Epub 2020 Sep 14.
10
The Paris System "atypical urothelial cells" category: can the current criteria be improved?巴黎系统“非典型尿路上皮细胞”类别:目前的标准能否得到改善?
J Am Soc Cytopathol. 2021 Jan-Feb;10(1):3-8. doi: 10.1016/j.jasc.2020.04.015. Epub 2020 Jun 5.